CD79b antibody
Quick Overview for CD79b antibody (ABIN7864895)
Target
See all CD79b (CD79B) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- CD79b (B-Cell Marker) Antibody
-
Specificity
- CD79 (also designated Ig ±/Ig ≤) is a heterodimer composed of ± chains, designated CD79A or MB-1, and ≤ chains, designated CD79B or B29. The B cell antigen receptor complex (BCR) is formed by the association of CD79 with a membrane immunoglobulin, such as IgM or IgD. The membrane immunoglobulins IgM and IgD achieve surface expression and antigen presentation function in response to CD79 association. The cytoplasmic tails of both CD79A and CD79B contain an ITAM (immuno-receptor tyrosine-based activation) motif, which acts to initiate the BCR signaling reactions by binding to and activating tyrosine kinases.
-
Purification
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant fragment of human CD79b protein (exact sequence is proprietary)
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- CD79b (CD79B) (CD79b Molecule, Immunoglobulin-Associated beta (CD79B))
-
Alternative Name
- CD79b
-
Background
-
AGM6, B-cell antigen receptor complex-associated protein beta chain, B-cell-specific glycoprotein B29, B29, B29/Ig-beta/CD79b, CD79b, Ig-beta, IGB, Immunoglobulin-associated B29 protein
Daudi or Ramos cells. Germinal center B-cells in a lymph node or tonsil.
-
Molecular Weight
- 39kDa
-
Gene ID
- 974, 89575
-
Pathways
- BCR Signaling
Target
-